Authors: Buckheit, RW Watson, K Fliakas-Boltz, V Russell, J Loftus, TL Osterling, MC Turpin, JA Pallansch, LA White, EL Lee, JW Lee, SH Oh, JW Kwon, HS Chung, SG Cho, EH

Citation: Rw. Buckheit et al., SJ-3366, a unique and highly potent nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1 (HIV-1) that also inhibits HIV-2, ANTIM AG CH, 45(2), 2001, pp. 393-400

Authors: Xu, GZ Micklatcher, M Silvestri, MA Hartman, TL Burrier, J Osterling, MC Wargo, H Turpin, JA Buckheit, RW Cushman, M

Citation: Gz. Xu et al., The biological effects of structural variation at the meta position of thearomatic rings and at the end of the alkenyl chain in the alkenyldiarylmethane series of non-nucleoside reverse transcriptase inhibitors, J MED CHEM, 44(24), 2001, pp. 4092-4113

Authors: Buckheit, RW White, EL Fliakas-Boltz, V Russell, J Stup, TL Kinjerski, TL Osterling, MC Weigand, A Bader, JP

Citation: Rw. Buckheit et al., Unique anti-human immunodeficiency virus activities of the nonnucleoside reverse transcriptase inhibitors calanolide A, costatolide, and dihydrocostatolide, ANTIM AG CH, 43(8), 1999, pp. 1827-1834